Fundraising Fox
Antoine Papiernik
InvestorChairman & Managing Partner at Sofinnova Partners
Paris, France
Writes $100K – $5M checks · typically $1.5M
Find your path to Antoine
Sign up to see every warm intro you have to Antoine
- Paths you didn't know you had: your email and LinkedIn already hold routes to Antoine. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Antoine Papiernik joined Sofinnova Partners in 1997 and is Chairman and Managing Partner, investing through the firm's flagship Capital Strategy in life sciences. He has been an initial investor and board member of numerous public and private companies including Actelion, Shockwave Medical, CoreValve and Recor Medical, and holds an MBA from the Wharton School; he has twice appeared on the Forbes Midas List.
Contact· published on Antoine's own website
Invests in
BiotechMedical Devices
Deals · 3
Galvanize TherapeuticsBoard seat
via Sofinnova Partners · filed Sep 2025 · $141.1M raise
Shockwave MedicalBoard seat
via Sofinnova Partners · filed Dec 2018 · $15.7M raise
RgenixBoard seat
via Sofinnova Partners · filed Jun 2016 · $33M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
ActelionGalvanizeHighlifeMay HealthMovetisNoema PharmaNovusPharmaPi-CardiaProQRReflexionmedicalReflexionmedicalSafehealTissium
Investor
Addex TherapeuticsAltamira TherapeuticsCoreValveCorvent MedicalEthical Oncology Science (EOS)FoveaFovea PharmaceuticalsHighlifeHome BiosciencesLectus TherapeuticsMainstay MedicalMay HealthMoon SurgicalMovetisNoema PharmaPixium VisionReCor MedicalRefleXion MedicalSafehealTissium
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Sofinnova Partners
Network8
Investors connected to Antoine in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Antoine Papiernik?
- Antoine Papiernik joined Sofinnova Partners in 1997 and is Chairman and Managing Partner, investing through the firm's flagship Capital Strategy in life sciences. He has been an initial investor and board member of numerous public and private companies including Actelion, Shockwave Medical, CoreValve and Recor Medical, and holds an MBA from the Wharton School; he has twice appeared on the Forbes Midas List.
- Where does Antoine Papiernik work?
- Antoine Papiernik is Chairman & Managing Partner at Sofinnova Partners.
- What does Antoine Papiernik invest in?
- Antoine Papiernik invests in Biotech, Medical Devices.
- What check size does Antoine Papiernik write?
- Antoine Papiernik typically writes checks of $100K – $5M.
- What boards does Antoine Papiernik sit on?
- Antoine Papiernik holds tracked board seats at Actelion, Galvanize, Galvanize Therapeutics, Highlife, May Health, Movetis, Noema Pharma, NovusPharma, Pi-Cardia, ProQR.
- What companies has Antoine Papiernik invested in?
- Investments tracked here include Addex Therapeutics, Altamira Therapeutics, CoreValve, Corvent Medical, Ethical Oncology Science (EOS), Fovea, Fovea Pharmaceuticals, Galvanize Therapeutics, Highlife, Home Biosciences, Lectus Therapeutics, Mainstay Medical, and 10 more.
About this profile. Compiled from public sources — Sofinnova Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights